Effectiveness of dapagliflozin in nonalcoholic fatty liver disease in type 2 diabetes patients compared to sitagliptin and pioglitazone

被引：0
作者：
Koutsovasilis, A.
Sotiropoulos, A.
Bletsa, E.
Antoniou, A.
Tamvakos, C.
Ntionias, D.
Bousboulas, S.
Peppas, T.
机构：
[1] Gen Hosp Nikaia Piraeus, Dept Internal Med 3, Athens, Greece
[2] Gen Hosp Nikaia Piraeus, Ctr Diabet, Athens, Greece
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
[31]   Pioglitazone Improves Atherosclerosis-Related Biomarkers Independent of Obesity in Japanese Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease [J].
Suzuki, Yoshifumi ;
Hashimoto, Naotake ;
Sakuma, Yukie ;
Iwai, Rie ;
Tagui, Masako ;
Yoshida, Shohji .
DIABETES, 2010, 59 :A568-A568
[32]   Characteristics of Patients with Type 2 Diabetes without Nonalcoholic Fatty Liver Disease (NAFLD) [J].
Saenz, Enrique Valdez ;
Leiva, Eddison Godinez ;
Lomonaco, Romina ;
Marangi, Stephen A. ;
Kalavalapalli, Srilaxmi ;
Gonzalez, Maria A. ;
Chi, Xiaofei ;
Rocha, Andrea Ortiz ;
Mohseni, Yasmine ;
Barb, Diana ;
Gurka, Matthew J. ;
Sharma, Anu ;
Cusi, Kenneth .
DIABETES, 2023, 72
[33]   Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment [J].
Ciardullo, Stefano ;
Vergani, Michela ;
Perseghin, Gianluca .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
[34]   Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus [J].
Paola Portillo-Sanchez ;
Kenneth Cusi .
Clinical Diabetes and Endocrinology, 2 (1)
[35]   Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes in a Spanish Population [J].
Sanchez Bao, Ana M., Jr. ;
Bellido, Virginia ;
Tejera, Cristina ;
Bellido, Diego, Sr. .
DIABETES, 2020, 69
[36]   Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes [J].
不详 .
Nature Clinical Practice Nephrology, 2008, 4 (11) :584-584
[37]   Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes [J].
Targher, Giovanni ;
Valbusa, Filippo ;
Bonapace, Stafano ;
Bertolini, Lorenzo ;
Zenari, Luciano ;
Pichiri, Isabella ;
Mantovani, Alessandro ;
Zoppini, Giacomo ;
Bonora, Enzo ;
Barbieri, Enrico ;
Byrne, Christopher D. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (06) :663-669
[38]   Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action [J].
Bril, Fernando ;
Cusi, Kenneth .
DIABETES CARE, 2017, 40 (03) :419-430
[39]   Fasting Hyperglucagonemia in Patients with Nonalcoholic Fatty Liver Disease With and Without Type 2 Diabetes [J].
Junker, Anders E. ;
Gluud, Lise L. ;
Holst, Jens J. ;
Knop, Filip K. ;
Vils-Boll, Tina .
DIABETES, 2014, 63 :A467-A467
[40]   Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease [J].
Mantovani, Alessandro ;
Pernigo, Matteo ;
Bergamini, Corinna ;
Bonapace, Stefano ;
Lipari, Paola ;
Valbusa, Filippo ;
Bertolini, Lorenzo ;
Zenari, Luciano ;
Pichiri, Isabella ;
Dauriz, Marco ;
Zoppini, Giacomo ;
Barbieri, Enrico ;
Byrne, Christopher D. ;
Bonora, Enzo ;
Targher, Giovanni .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (08) :879-887
12345